Lepodisiran, a Small Intefering RNA, Could Lower Lp(a) by More than 95%
Presented at AHA 2023, phase 1 data for lepodisiran showcased a 97% reduction in lipoprotein(a) levels at the 608 mg dose.
Source: hcplive.com
Page 8 - Standard Deviation News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Standard Deviation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Standard Deviation Today - Breaking & Trending Today
Semaglutide 2.4 mg (Wegovy) Reduces Cardiovascular Risk in Overweight/Obesity with CVD
Full data from the SELECT trial offer insight into the 20% relative risk reduction associated with use of semaglutide 2.4 mg in patients with overweight or obesity and preexisting cardiovascular disease at AHA 2023.
Source: hcplive.com
Liberal Transfusion Strategy Could Improve Outcomes in Acute MI with Anemia
The MINT trial, which included 3504 patients with acute MI and anemia, shows a trend favoring liberal transfusion, indicating a potential for improved outcomes.
Source: hcplive.com
dhanteras: With 20% return, gold outshines Sensex since last Dhanteras. Is yellow metal the safest sparkler?
Gold's returns are neary two-fold in comparison to Nifty and Sensex which have delivered returns of 10.34% and 9.31%, respectively, since last Dhanteras which fell on October 22, 2022.
Source: indiatimes.com
FDA Approves Recor Medical's Paradise Ultrasound Renal Denervation System
On November 7, 2023, Record Medcial announced the FDA approval of their Paradise Ultrasound Renal Denervation system for the treatment of hypertension.
Source: hcplive.com